Pfizer announced this morning that it is selling its Capsugel business, which makes capsules and other drug delivery systems, to private equity firm Kohlberg Kravis Roberts for $2.38 billion in...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer's Capsugel Sale Could Set Stage For Other Divestitures
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account